Literature DB >> 6206236

Involvement of retrovirus reverse transcriptase-associated RNase H in the initiation of strong-stop (+) DNA synthesis and the generation of the long terminal repeat.

R Resnick, C A Omer, A J Faras.   

Abstract

Reconstructed enzymatic reactions containing purified reverse transcriptase and defined analog substrates which mimic those purported to be natural substances for reverse transcription in vivo were employed to delineate the mechanism of strong-stop (+) DNA synthesis. Our analysis of this system has indicated that strong-stop (+) DNA synthesis is initiated after the introduction of a nick in the viral RNA genome between a polypurine sequence and an inverted repeat that represents the end of the long terminal repeat. Since inhibitors of the reverse transcriptase-associated RNase H activity prevent the introduction of the nick and the synthesis of strong-stop (+) DNA synthesis, it appears that this particular reverse transcriptase-associated enzymatic activity is responsible for the initiation of strong-stop (+) DNA. Our data also indicated that the RNase H activity creates a second nick in the viral RNA genome 11 nucleotides upstream from the strong-stop (+) DNA initiation site since the strong-stop (+) DNA synthesized in these reactions is covalently linked to an oligoribonucleotide 11 residues in length. Nucleotide sequence analysis of the oligoribonucleotide primer molecule indicated that a single homogenous oligomer was associated with strong-stop (+) DNA exhibiting the sequence rArGrGrGrArGrGrGrGrGrA. The oligoribonucleotide primer can be removed from strong-stop (+) DNA by the purified reverse transcriptase, which creates a nick at the junction between the primer and strong-stop (+) DNA. These data demonstrate that the initiation of strong-stop (+) DNA synthesis is mediated by RNase H and that the site of initiation is exactly at the end of the long terminal repeat, providing evidence for yet another function of this reverse transcriptase-associated enzymatic activity in the synthesis of retrovirus DNA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206236      PMCID: PMC255849     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Kinetics of synthesis, structure and purification of avian sarcoma virus-specific DNA made in the cytoplasm of acutely infected cells.

Authors:  H E Varmus; S Heasley; H J Kung; H Oppermann; V C Smith; J M Bishop; P R Shank
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

2.  Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification.

Authors:  K R Yamamoto; B M Alberts; R Benzinger; L Lawhorne; G Treiber
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

3.  Evidence for involvement of an RNA primer in initiation of strong-stop plus DNA synthesis during reverse transcription in vitro.

Authors:  C A Omer; R Resnick; A J Faras
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

4.  Specific inhibition of DNA polymerase-associated RNase H by DNA.

Authors:  M J Modak; S L Marcus
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

Review 5.  The reverse transcriptase.

Authors:  I M Verma
Journal:  Biochim Biophys Acta       Date:  1977-03-21

6.  The use of thin acrylamide gels for DNA sequencing.

Authors:  F Sanger; A R Coulson
Journal:  FEBS Lett       Date:  1978-03-01       Impact factor: 4.124

7.  RNase H hydrolysis of the 5' terminus of the avian sarcoma virus genome during reverse transcription.

Authors:  M S Collett; P Dierks; J T Parsons; A J Faras
Journal:  Nature       Date:  1978-03-09       Impact factor: 49.962

8.  Specific binding of tryptophan transfer RNA to avian myeloblastosis virus RNA-dependent DNA polymerase (reverse transcriptase).

Authors:  A Panet; W A Haseltine; D Baltimore; G Peters; F Harada; J E Dahlberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

9.  Mechanism of action of ribonuclease H isolated from avian myeloblastosis virus and Escherichia coli.

Authors:  J P Leis; I Berkower; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

10.  Mapping adenines, guanines, and pyrimidines in RNA.

Authors:  H Donis-Keller; A M Maxam; W Gilbert
Journal:  Nucleic Acids Res       Date:  1977-08       Impact factor: 16.971

View more
  39 in total

1.  The plus strand is discontinuous in a subpopulation of unintegrated HIV-1 DNA.

Authors:  O Hungnes; E Tjotta; B Grinde
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Specificities involved in the initiation of retroviral plus-strand DNA.

Authors:  G X Luo; L Sharmeen; J Taylor
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

3.  Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function.

Authors:  N Tanese; A Telesnitsky; S P Goff
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis.

Authors:  J M Lien; C E Aldrich; W S Mason
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

5.  Quantitative analysis of RNA cleavage during RNA-directed DNA synthesis by human immunodeficiency and avian myeloblastosis virus reverse transcriptases.

Authors:  J J DeStefano; L M Mallaber; P J Fay; R A Bambara
Journal:  Nucleic Acids Res       Date:  1994-09-11       Impact factor: 16.971

6.  Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase.

Authors:  J J DeStefano; L M Mallaber; P J Fay; R A Bambara
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

7.  Expression of an Mg2+-dependent HIV-1 RNase H construct for drug screening.

Authors:  Richard V Farias; Deborah A Vargas; Andres E Castillo; Beatriz Valenzuela; Marie L Coté; Monica J Roth; Oscar Leon
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

8.  Plus-strand origin for human immunodeficiency virus type 1: implications for integration.

Authors:  K A Pullen; J J Champoux
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

9.  A transformation-competent recombinant between v-src and Rous-associated virus RAV-1.

Authors:  J Svoboda; J C Kandala; J Geryk; J Pichrtová; R V Guntaka
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

10.  Extended minus-strand DNA as template for R-U5-mediated second-strand transfer in recombinational rescue of primer binding site-modified retroviral vectors.

Authors:  J G Mikkelsen; A H Lund; K Dybkaer; M Duch; F S Pedersen
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.